181 related articles for article (PubMed ID: 34590275)
1. Exploring Candidate Human Synthetic Lethal Interactions Through siRNA and Quantitative Imaging-Based Approaches.
Jeusset LM; McManus KJ
Methods Mol Biol; 2021; 2381():151-173. PubMed ID: 34590275
[TBL] [Abstract][Full Text] [Related]
2. Ranking novel cancer driving synthetic lethal gene pairs using TCGA data.
Ye H; Zhang X; Chen Y; Liu Q; Wei J
Oncotarget; 2016 Aug; 7(34):55352-55367. PubMed ID: 27438146
[TBL] [Abstract][Full Text] [Related]
3. Employing Cross-Species Approaches to Construct Humanized Genetic Interaction Networks.
Jeusset LM; McManus KJ
Methods Mol Biol; 2021; 2381():115-133. PubMed ID: 34590273
[TBL] [Abstract][Full Text] [Related]
4. Identifying synthetic lethal targets using CRISPR/Cas9 system.
Dhanjal JK; Radhakrishnan N; Sundar D
Methods; 2017 Dec; 131():66-73. PubMed ID: 28710008
[TBL] [Abstract][Full Text] [Related]
5. Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens.
Srivatsa S; Montazeri H; Bianco G; Coto-Llerena M; Marinucci M; Ng CKY; Piscuoglio S; Beerenwinkel N
Nat Commun; 2022 Dec; 13(1):7748. PubMed ID: 36517508
[TBL] [Abstract][Full Text] [Related]
6.
Sun N; Petiwala S; Lu C; Hutti JE; Hu M; Hu M; Domanus MH; Mitra D; Addo SN; Miller CP; Chung N
CRISPR J; 2019 Aug; 2():230-245. PubMed ID: 31436504
[TBL] [Abstract][Full Text] [Related]
7. Approaches to identifying synthetic lethal interactions in cancer.
Thompson JM; Nguyen QH; Singh M; Razorenova OV
Yale J Biol Med; 2015 Jun; 88(2):145-55. PubMed ID: 26029013
[TBL] [Abstract][Full Text] [Related]
8. Synthetic lethality-based prediction of anti-SARS-CoV-2 targets.
Pal LR; Cheng K; Nair NU; Martin-Sancho L; Sinha S; Pu Y; Riva L; Yin X; Schischlik F; Lee JS; Chanda SK; Ruppin E
bioRxiv; 2021 Sep; ():. PubMed ID: 34545363
[TBL] [Abstract][Full Text] [Related]
9. Exploring the genetic space of the DNA damage response for cancer therapy through CRISPR-based screens.
Wilson J; Loizou JI
Mol Oncol; 2022 Nov; 16(21):3778-3791. PubMed ID: 35708734
[TBL] [Abstract][Full Text] [Related]
10. Synthetic lethality-based prediction of anti-SARS-CoV-2 targets.
Pal LR; Cheng K; Nair NU; Martin-Sancho L; Sinha S; Pu Y; Riva L; Yin X; Schischlik F; Lee JS; Chanda SK; Ruppin E
iScience; 2022 May; 25(5):104311. PubMed ID: 35502318
[TBL] [Abstract][Full Text] [Related]
11. CSSLdb: Discovery of cancer-specific synthetic lethal interactions based on machine learning and statistic inference.
Dou Y; Ren Y; Zhao X; Jin J; Xiong S; Luo L; Xu X; Yang X; Yu J; Guo L; Liang T
Comput Biol Med; 2024 Mar; 170():108066. PubMed ID: 38310806
[TBL] [Abstract][Full Text] [Related]
12. A high-throughput siRNA screening platform to identify MYC-synthetic lethal genes as candidate therapeutic targets.
Grandori C
Methods Mol Biol; 2013; 1012():187-200. PubMed ID: 24006065
[TBL] [Abstract][Full Text] [Related]
13. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
Karimpour M; Totonchi M; Behmanesh M; Montazeri H
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
[TBL] [Abstract][Full Text] [Related]
14. Overcoming selection bias in synthetic lethality prediction.
Seale C; Tepeli Y; Gonçalves JP
Bioinformatics; 2022 Sep; 38(18):4360-4368. PubMed ID: 35876858
[TBL] [Abstract][Full Text] [Related]
15. Multi-omics characterization of synthetic lethality-related molecular features: implications for SL-based therapeutic target screening.
Weng S; Ruan H
FEBS J; 2023 Mar; 290(6):1477-1480. PubMed ID: 36461713
[TBL] [Abstract][Full Text] [Related]
16. Synthetic Lethality Screening with Recursive Feature Machines.
Cai C; Radhakrishnan A; Uhler C
bioRxiv; 2023 Dec; ():. PubMed ID: 38106093
[TBL] [Abstract][Full Text] [Related]
17. Link synthetic lethality to drug sensitivity of cancer cells.
Wang R; Han Y; Zhao Z; Yang F; Chen T; Zhou W; Wang X; Qi L; Zhao W; Guo Z; Gu Y
Brief Bioinform; 2019 Jul; 20(4):1295-1307. PubMed ID: 29300844
[TBL] [Abstract][Full Text] [Related]
18. Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality.
Jerby-Arnon L; Pfetzer N; Waldman YY; McGarry L; James D; Shanks E; Seashore-Ludlow B; Weinstock A; Geiger T; Clemons PA; Gottlieb E; Ruppin E
Cell; 2014 Aug; 158(5):1199-1209. PubMed ID: 25171417
[TBL] [Abstract][Full Text] [Related]
19. Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer.
Tang YC; Ho SC; Tan E; Ng AWT; McPherson JR; Goh GYL; Teh BT; Bard F; Rozen SG
Breast Cancer Res; 2018 Mar; 20(1):22. PubMed ID: 29566768
[TBL] [Abstract][Full Text] [Related]
20. Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer.
Srihari S; Singla J; Wong L; Ragan MA
Biol Direct; 2015 Oct; 10():57. PubMed ID: 26427375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
